Moolec Science

MLEC

Market cap $14.5M

Overview Fund Activity

1.33 USD

-0.05

3.62%

At close Updated Sep 15, 4:00 PM EDT

1 day

-3.62%

5 days

14.66%

1 month

-45.93%

3 months

-81.27%

6 months

-84.2%

Year to date

-83.8%

1 year

-85.68%

5 years

-98.54%

10 years

-98.54%

About: Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

Employees: 52

Healthcare Biotechnology

0

Funds holding %

of 7,463 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

0.04% less ownership

Funds ownership: 0.04% [Q1] → 0% (-0.04%) [Q2]

78% less funds holding

Funds holding: 9 [Q1] → 2 (-7) [Q2]

99% less capital invested

Capital invested by funds: $82K [Q1] → $775 (-$81.3K) [Q2]

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 7

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

See Fund Rankings

Financial journalist opinion

Moolec Science Secures Regulatory Approval for Safflower GLASO Technology in Argentina, Expands U.S. Acreage, and Strengthens Leadership With CFO Appointment

WARWICK, GB / ACCESS Newswire / September 11, 2025 / Moolec Science Limited, a wholly-owned subsidiary of Moolec Science SA (NASDAQ:MLEC)("the Company"; "Moolec"), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced regulatory approval in Argentina for its safflower GLASO [1] technology, the expansion of U.S. acreage to support revenue-generating activities, and the appointment of a new Chief Financial Officer to strengthen its leadership team. Regulatory Milestone for GLASO[1] Technology in Argentina In Argentina, the National Service for Agri-Food Health and Quality (SENASA) granted feed and food approval for Moolec's proprietary Safflower GLASO [1] technology.

Moolec Science Secures Regulatory Approval for Safflower GLASO Technology in Argentina, Expands U.S. Acreage, and Strengthens Leadership With CFO Appointment

Moolec Science Secures Core U.S. Patent for Piggy Sooy(TM), Soybean Expressing Up to 30% of Animal Protein

WARWICK, GB / ACCESS Newswire / June 18, 2025 / Moolec Science Limited a wholly-owned subsidiary of Moolec Science SA (NASDAQ:MLEC; "The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its proprietary groundbreaking Piggy Sooy™ technology - soybean plant engineered to express high levels of porcine hemeproteins in their seeds. Moolec Science Logo Piggy Sooy™ is the first patented soybean technology designed to produce high levels of porcine hemeproteins directly in the seeds.

Moolec Science Secures Core U.S. Patent for Piggy Sooy(TM), Soybean Expressing Up to 30% of Animal Protein

Moolec Science Announces Successful Closing of Business Combination, Expanding Across Life Sciences and Food-Tech

GRAND CAYMAN, CAYMAN ISLANDS / ACCESS Newswire / June 17, 2025 / Moolec Science SA (NASDAQ:MLEC) ("The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today announced the successful closing of its previously announced strategic business combination (the "Business Combination") with Bioceres Group Limited ("Bioceres Group"), Gentle Technologies Corp ("Gentle Tech"), and Nutrecon LLC ("Nutrecon"). With the closing, Moolec emerges as the parent company of a significantly expanded and enhanced enterprise at the forefront of sustainable life sciences and food-tech innovation.

Moolec Science Announces Successful Closing of Business Combination, Expanding Across Life Sciences and Food-Tech

Moolec Science Regains NASDAQ Compliance

GRAND CAYMAN, CAYMAN ISLANDS / ACCESS Newswire / June 11, 2025 / Moolec Science SA (NASDAQ:MLEC) "The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today announced that it regained compliance with Listing Rule 5550(a)(2) (the "Bid Price Rule"), as required by the Nasdaq Hearings Panel's ("Panel") decision dated April 3, 2025. On May 14, 2025, the Company effected a 1-for-10 reverse stock split, and the common shares have since had a closing bid price of at least $1.

Moolec Science Regains NASDAQ Compliance

Moolec Science Announces Effectiveness of Reverse Stock Split

LUXEMBOURG, LU / ACCESS Newswire / May 12, 2025 / Moolec Science SA (NASDAQ:MLEC; the "Company" or "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today announced that, in accordance with the resolutions passed at the extraordinary general meeting of shareholders held on April 22, 2025, and the resolutions adopted by the Company's board of directors on the same date, the Company has approved a reverse stock split at a consolidation ratio of one-for-ten (1-for-10). As a result, every ten ordinary shares of the Company, with a par value of US$0.01 per share (the "Shares"), issued and outstanding will automatically, and without any action required on the part of the holders, be consolidated into one validly issued, fully paid, and non-assessable Share, with no change to the par value per share (the "Reverse Stock Split").

Moolec Science Announces Effectiveness of Reverse Stock Split

Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms

LUXEMBOURG, LU / ACCESS Newswire / April 21, 2025 / Moolec Science SA (NASDAQ:MLEC) ("The Company" or "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today announced that it has entered into a Business Combination Agreement (the "BCA") with Bioceres Group Limited ("Bioceres Group") and other related entities in an all-stock transaction (the "Business Combination"). Subject to the terms and conditions of the BCA, which was signed on April 17, 2025, several parties will transfer their respective holdings in Bioceres Group, Nutrecon LLC ("Nutrecon"), and Gentle Technologies Corp ("Gentle Tech", and together with Bioceres Group and Nutrecon, the "Contributed Entities"), resulting in an enlarged corporate structure with Moolec as the parent company.

Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms

Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms

LUXEMBOURG, LU / ACCESS Newswire / April 21, 2025 / Moolec Science SA (NASDAQ:MLEC) ("The Company" or "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today announced that it has entered into a Business Combination Agreement (the "BCA") with Bioceres Group Limited ("Bioceres Group") and other related entities in an all-stock transaction (the "Business Combination"). Subject to the terms and conditions of the BCA, which was signed on April 17, 2025, several parties will transfer their respective holdings in Bioceres Group, Nutrecon LLC ("Nutrecon"), and Gentle Technologies Corp ("Gentle Tech", and together with Bioceres Group and Nutrecon, the "Contributed Entities"), resulting in an enlarged corporate structure with Moolec as the parent company.

Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms

Moolec Received Nasdaq Staff Determination Letter

LUXEMBOURG, LU / ACCESS Newswire / March 17, 2025 / Moolec Science SA (NASDAQ:MLEC), a public limited liability company (société anonyme) governed by the laws of the Grand Duchy of Luxembourg, having its registered office at 17, Boulevard F.W. Raiffeisen, L-2411 Luxembourg, Grand Duchy of Luxembourg, and registered with the Luxembourg Register of Commerce and Companies (Registre de Commerce et des Sociétés de Luxembourg) under registration number B268440 ("Moolec," the "Company," "we," "us" or "our") received a letter on March 11, 2025 (the "Determination Letter"), from the staff of the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, as the closing bid price of its listed securities has remained at less than $1.00 per share over 30 consecutive business days as of September 10, 2024, and has not increased to $1.00 for more than 10 consecutive business days thereafter, the Company has not regained compliance with Nasdaq Listing Rule 5550(a)(2).

Moolec Received Nasdaq Staff Determination Letter

Moolec Has Received USDA Approval for the First Genetically Modified Pea in History

LUXEMBOURG / ACCESSWIRE / October 16, 2024 / Moolec Science SA (NASDAQ:MLEC) ("the Company"), a leader in Molecular Farming technology, announced today that the U.S. Department of Agriculture's ("USDA") Animal and Plant Health Inspection Service ("APHIS") has completed its Regulatory Status Review ("RSR") for the Company's genetically engineered ("GE") peas which produce iron through bovine meat proteins. This is the third regulatory clearance from USDA-APHIS achieved by Moolec in an 18-month window, alongside its genetically engineered safflower and soybean for GLASO™ and Piggy Sooy™ products, respectively.

Moolec Has Received USDA Approval for the First Genetically Modified Pea in History

Moolec Science (MLEC) Q4 2024 Earnings Call Transcript

Moolec Science SA (NASDAQ:MLEC ) Q4 2024 Earnings Conference Call October 2, 2024 8:30 AM ET Company Participants Gaston Paladini - Chief Executive Officer Jose Lopez Lecube - Chief Financial Officer Martin Salinas - Chief Technology Officer Amit Dhingra - Chief Science Officer Bill Zima - ICR Strategic Communications Conference Call Participants Scott Fortune - Roth Capital Operator Good morning and welcome to Moolec Science's fourth quarter and full fiscal year 2024 conference call. My name is Bill Zima of ICR Strategic Communications and Advisory.

Moolec Science (MLEC) Q4 2024 Earnings Call Transcript

See News Rankings

Charts implemented using Lightweight Charts™